Skip to Main Content

Author Details

Tobias Maurer
Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
2002
217
53
PMIDPaper TitleJournal TitlePublished Year
36184537Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection.Eur Urol Focus2023
37515651Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.World J Urol2023
37894375EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer.Cancers (Basel)2023
35835582Feasibility of <sup>99m</sup>Tc-MIP-1404 for SPECT/CT Imaging and Subsequent PSMA-Radioguided Surgery in Early Biochemically Recurrent Prostate Cancer: A Case Series of 9 Patients.J Nucl Med2023
35718637Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery.Eur Urol2023
37414702Diagnostic Performance and Safety of Positron Emission Tomography with <sup>18</sup>F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).Eur Urol2023
37230531Delayed Imaging Improves Lesion Detectability in [<sup>99m</sup>Tc]Tc-PSMA-I&amp;S SPECT/CT in Recurrent Prostate Cancer.J Nucl Med2023
37261472Development and external validation of a multivariable [<sup>68</sup>Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer.Eur J Nucl Med Mol Imaging2023
36656332Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?World J Urol2023
36694344Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease.Mol Oncol2023
36473945Using PSMA imaging for prognostication in localized and advanced prostate cancer.Nat Rev Urol2023
36807497[Metastasis-directed therapy in solitary oligorecurrent prostate cancer without androgen deprivation therapy-a commentary].Urologie2023
36935345Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2).Eur Urol2023
36604297Prostate-specific Membrane Antigen-radioguided Surgery Facilitates Pelvic Lymph Node Dissection During Radical Prostatectomy for the Treatment of Locally Advanced Prostate Cancer with Regional Lymph Node Metastases.Eur Urol Oncol2023
36596346Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus.Int J Radiat Oncol Biol Phys2023
35986781Ultrasound-based "CEUS-Bosniak"classification for cystic renal lesions: an 8-year clinical experience.World J Urol2023
34255130The added value of PSMA PET/MR radiomics for prostate cancer staging.Eur J Nucl Med Mol Imaging2022
35585014Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry.Clin Genitourin Cancer2022
35501610Pan-segmental intraprostatic lesions involving mid-gland and apex of prostate (mid-apical lesions): assessing the true value of extreme apical biopsy cores.World J Urol2022
35697600EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [<sup>177</sup>Lu]Lu-PSMA Radioligand Therapy.Eur Urol Oncol2022
35367165[<sup>68</sup>Ga]Ga-PSMA Versus [<sup>18</sup>F]PSMA Positron Emission Tomography/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review of the Literature.Eur Urol Oncol2022
35393348Validation of <sup>18</sup>F-rhPSMA-7 and <sup>18</sup>F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer.J Nucl Med2022
35945234New diterpenes from the marine sponge Spongionella sp. overcome drug resistance in prostate cancer by inhibition of P-glycoprotein.Sci Rep2022
34992154Utility of <sup>18</sup>F-rhPSMA-7.3 PET for Imaging of Primary Prostate Cancer and Preoperative Efficacy in N-Staging of Unfavorable Intermediate- to Very High-Risk Patients Validated by Histopathology.J Nucl Med2022
35198399Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer.Asian J Urol2022
35138414[Prostate-specific membrane antigen positron emission tomography (PSMA PET) for urologists-when and which tracer?]Urologe A2022
35339318Robot-assisted Prostate-specific Membrane Antigen-radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study.Eur Urol2022
34555925Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions.J Urol2022
34340868PSMA PET predicts metastasis-free survival in the setting of salvage radiotherapy after radical prostatectomy.Urol Oncol2022
32372159Final results of the PräVAC trial: prevention of wound complications following inguinal lymph node dissection in patients with penile cancer using epidermal vacuum-assisted wound closure.World J Urol2021
33829716Contemporary update of SPECT tracers and novelties in radioguided surgery: a perspective based on urology.Q J Nucl Med Mol Imaging2021
33642617[Corona child studies "Co-Ki": first results of a Germany-wide register on mouth and nose covering (mask) in children].Monatsschr Kinderheilkd2021
33535796Regional Lymph Node Metastasis on Prostate Specific Membrane Antigen Positron Emission Tomography Correlates with Decreased Biochemical Recurrence-Free and Therapy-Free Survival after Radical Prostatectomy: A Retrospective Single-Center Single-Arm Observational Study.J Urol2021
33863885An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.Nat Commun2021
33637464Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review.Eur Urol Oncol2021
33558200Prostate-specific Membrane Antigen Radioguidance for Salvage Lymph Node Dissection in Recurrent Prostate Cancer.Eur Urol Focus2021
33530110[PSMA radioligand therapy could pose infrastructural challenges for nuclear medicine: results of a basic calculation for the capacity planning of nuclear medicine beds in the German hospital sector].Nuklearmedizin2021
34786563Possible Role of Circulating Tumour Cells for Prediction of Salvage Lymph Node Dissection Outcome in Patients with Early Prostate Cancer Recurrence.Eur Urol Open Sci2021
34417907PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy.EJNMMI Res2021
34479375Correction: Clinical impact of whole-body 68Ga-PSMA I&amp;T PET/CT: lesion frequency and added benefit in lower extremities.Nuklearmedizin2021
34105340Image-guided surgery: from classical techniques to novel aspects and approaches.Q J Nucl Med Mol Imaging2021
34105337Implementation of radioguided surgery in prostate cancer.Q J Nucl Med Mol Imaging2021
34078552Reply to Fabio C.M. Torricelli and Rafael F. Coelho's Letter to the Editor re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44.Eur Urol2021
34036733Significant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissection.BJU Int2021
34110033Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort.Prostate2021
34047401Radical prostatectomy improves survival in selected metastatic prostate cancer patients: A North American population-based study.Int J Urol2021
34021954Early prostate cancer recurrence with prostate-specific membrane antigen positron emission tomography positive unilateral pelvic lesion(s): is one-sided salvage extended lymph node dissection enough? (ProSTone, NCT04271579).BJU Int2021
33996487Multimodal therapy in oligometastatic prostate cancer: A glimpse into the future?Asian J Urol2021
33162611[Corona in Children: the Co-Ki Study].Monatsschr Kinderheilkd2021
33188151Positive Predictive Value and Correct Detection Rate of <sup>18</sup>F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard.J Nucl Med2021
  • 1 - 50 of 217

Recommended Authors

Giovanni Motterle
Mayo Clinic
Career Start Year 2017
Number of shared co-authors 14
R Jeffrey Karnes
Mayo Clinic
Career Start Year 2013
Number of shared co-authors 9
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 12
Giorgio Gandaglia
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Career Start Year 2012
Number of shared co-authors 18
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Career Start Year 2010
Number of shared co-authors 42
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 6
Alastair D Lamb
University of Oxford
Career Start Year 2007
Number of shared co-authors 7
Baris Turkbey
National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 13
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 4
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 8
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Career Start Year 2003
Number of shared co-authors 18
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 3
Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Robert Jeffrey Karnes
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 39
Wolfgang Lilleby
Oslo University Hospital
Career Start Year 1999
Number of shared co-authors 16
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 22
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 3
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 12
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 24
Alan Thompson
The Royal Marsden NHS Foundation Trust
Career Start Year 1996
Number of shared co-authors 3
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 19
Xavier Maldonado
Hospital Universitari Vall d'Hebron
Career Start Year 1994
Number of shared co-authors 12
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 8
Anthony V D'Amico
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 30
Mark Frydenberg
Monash University
Career Start Year 1988
Number of shared co-authors 22
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 21
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 14
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 34
Mack Roach
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 30
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 4

Collaborators

Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Co-authored papers 31
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Co-authored papers 17
Andrei Gafita
Johns Hopkins University School of Medicine
Co-authored papers 6
Jeremie Calais
university of california los angeles
Co-authored papers 6
Thomas A Hope
University of California san francisco
Co-authored papers 5
Ithaar H Derweesh
university of california san diego School of Medicine
Co-authored papers 5
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers 5
Francisco X Real
Spanish National Cancer Research Centre-CNIO
Co-authored papers 4
Nassir Navab
Technische Universitat Munchen
Co-authored papers 4
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Co-authored papers 4
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Co-authored papers 4
N??ria Malats
Spanish National Cancer Research Centre
Co-authored papers 4
Fred Saad
University of Montreal Health Center
Co-authored papers 3
Arnulf Stenzl
Eberhard Karls University of Tubingen
Co-authored papers 2
Johannes Czernin
university of california los angeles
Co-authored papers 2
Anders Bjartell
Skane University Hospital, Lund University
Co-authored papers 2
Piet Ost
Ghent University, GZA Ziekenhuizen
Co-authored papers 2
Ewout W Steyerberg
Leiden University Medical Center
Co-authored papers 2
Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
Co-authored papers 2
Gernot Marx
University Hospital RWTH Aachen
Co-authored papers 2
Amar U Kishan
University of California los angeles
Co-authored papers 2
Edmund Neugebauer
Center for Health Services Research, Brandenburg Medical School Theodor Fontane
Co-authored papers 2
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 2
Kai Zacharowski
Goethe University, University Hospital Frankfurt
Co-authored papers 2
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Ulrich Sch??ller
University Medical Center Hamburg-Eppendorf
Co-authored papers 1
Hendrik Van Poppel
University Hospitals Leuven
Co-authored papers 1
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 1
Devin N Patel
university of california san diego School of Medicine
Co-authored papers 1
Mathieu Hatt
INSERM
Co-authored papers 1
Release 1.2